Clinical Trials Browser

Terminated × Ovarian Neoplasms × Trabectedin × Clear all

NCT03164980 2025-03-20

COMPASS

Phase 4 Terminated

89 enrolled 20 charts

Ovarian Neoplasms, Recurrence

NCT03690739 2022-02-24

Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer

Phase 3 Terminated

Ovarian Neoplasms